Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0909 BTS20 master protocols charticle
BioCentury & Infogram

Back to School 2020

COVID-19: a vote of confidence in platform trials

Sep 10, 2020 | 12:26 AM GMT

The rapid adoption of master protocol trials for COVID-19 therapies was a collective acknowledgement that the trial designs

Read the full 490 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers